Facilitating early-in-day discharge for multiple sclerosis patients treated with intravenous methylprednisolone: A quality improvement (QI) Project: DMAIC phase: Control

Research output: Chapter in Book/Report/Conference proceedingChapter

Fingerprint

Dive into the research topics of 'Facilitating early-in-day discharge for multiple sclerosis patients treated with intravenous methylprednisolone: A quality improvement (QI) Project: DMAIC phase: Control'. Together they form a unique fingerprint.